Artificial intelligence-based deep learning algorithms for ground-glass opacity nodule detection: A review

Narra J 2025 AI 5 Explanations View Original
Original Paper (PDF)

Unable to display PDF. Download it here or view on PMC.

Plain-English Explanations
Pages 1-2
Why Ground-Glass Opacity Detection Matters in Lung Cancer

Clinical Significance of GGOs Ground-glass opacity (GGO) nodules are hazy, partially transparent lesions visible on CT scans where the lung appears like frosted glass. They represent early-stage lung changes that can include early adenocarcinoma in situ, pre-invasive lesions, and viral pneumonias. Detecting and characterizing GGOs accurately is critical because early-stage GGO-associated lung cancers are highly curable with surgery.

Human Detection Limitations Traditional high-resolution CT (HRCT) review by radiologists achieves sensitivity of only 41-52% and specificity of 56-63% for GGO detection - alarmingly poor performance for a potentially curative early cancer finding. AI deep learning systems offer the potential to substantially improve these metrics.

Review Scope Shah and colleagues performed a systematic review of deep learning algorithms specifically designed for GGO detection, applying QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) to assess the quality of included studies and synthesize performance data across 18 qualifying studies.

TL;DR: This systematic review used QUADAS-2 to evaluate 18 deep learning GGO detection studies, finding AI sensitivity up to 99.1% versus only 41-52% for traditional radiologist review.
Pages 2-3
Systematic Review Methodology and QUADAS-2 Quality Assessment

Literature Search The search covered four databases: PubMed (820 records), Google Scholar (87), Scopus (4,327), and ScienceDirect (13), totaling 5,247 initial records. After removing 740 duplicates and applying inclusion/exclusion criteria, 18 studies were included in the final review.

QUADAS-2 Framework The QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) tool evaluates studies across four domains: patient selection, index test (AI algorithm), reference standard, and flow/timing. This framework helps identify potential sources of bias and applicability concerns that could inflate or deflate reported performance metrics.

Diversity of Models Reviewed The 18 included studies covered a wide range of deep learning architectures, including COVIDiag, CovAI-Net, CoLe-CNN+, COVID-Net CT-2, CovXNet, DeepCOVID-XR, SqueezeNet, CoroDet, WOANet, DenseNet-121, uAI-ChestCare, DRENet, DeepLN, and CV19-NET - providing a comprehensive landscape of the deep learning approaches applied to this problem.

TL;DR: 5,247 records were screened from four databases, yielding 18 studies covering 14 distinct deep learning models, each assessed for quality using the QUADAS-2 framework.
Pages 3-5
Performance Leaders: DenseNet-121 and WOANet

Top Performer DenseNet-121 achieved the highest reported accuracy among all reviewed models at 99.48%. DenseNet architectures use dense connections between layers - each layer receives feature maps from all preceding layers - which promotes feature reuse and enables very deep networks to train effectively without vanishing gradient problems.

WOANet Results WOANet (Whale Optimization Algorithm Network) achieved accuracy of 98.78%, sensitivity of 98.37%, and specificity of 99.19%. These balanced metrics across sensitivity and specificity are particularly important clinically, as high sensitivity ensures few cancers are missed while high specificity minimizes unnecessary follow-up procedures.

Range Across Models AI sensitivity ranged from 71% to 99.1% and specificity from 77% to 100% across all reviewed models, reflecting substantial variation in dataset characteristics, training methodology, and validation approaches. This wide range underscores the importance of rigorous evaluation protocols.

TL;DR: DenseNet-121 led with 99.48% accuracy, WOANet achieved 98.78% accuracy with balanced 98.37% sensitivity and 99.19% specificity, vastly outperforming traditional radiologist detection rates.
Pages 5-6
AI vs. Traditional CT: A Dramatic Performance Gap

Benchmark Comparison The contrast between AI performance and traditional HRCT review is striking. Traditional radiologist review achieves sensitivity of only 41-52% and specificity of 56-63%, meaning radiologists miss roughly half of GGOs and incorrectly flag nearly half of normal CT findings as suspicious.

Why Human Performance Lags GGOs are subtle, often small, and their haziness makes them blend into surrounding lung parenchyma. Radiologist fatigue, reader variability, and the sheer volume of CT slices to review contribute to suboptimal performance. AI systems are not subject to fatigue and can consistently apply learned detection criteria across all slices.

Quality Assessment Findings QUADAS-2 evaluation revealed that many included studies had quality concerns in patient selection (often retrospective, selected datasets) and reference standard (not all used pathological confirmation as the gold standard), which may partially explain the very high AI performance metrics - performance on selected datasets may not reflect real-world clinical performance.

TL;DR: AI outperforms traditional CT reading dramatically (sensitivity up to 99% vs. 41-52%), but QUADAS-2 analysis revealed quality concerns in many studies that may partially inflate performance estimates.
Pages 6-7
Path to Clinical Deployment and Research Priorities

Screening Program Integration The AI models reviewed here demonstrate performance far exceeding human radiologist GGO detection rates, making them strong candidates for integration into lung cancer CT screening programs where sensitivity is paramount - every missed GGO potentially represents a missed early-stage cancer.

Prospective Validation Need A consistent theme from QUADAS-2 evaluation is that most studies used retrospective, often enriched datasets. Prospective validation in consecutive clinical screening populations - where GGO prevalence is much lower than in curated research datasets - is essential before clinical deployment.

Explainability Requirement For radiologists to trust and appropriately use AI GGO detection tools, models need to provide interpretable outputs - highlighting the location and characteristics of detected opacities rather than simply outputting a binary detection flag. Integration of explainability frameworks like Grad-CAM or LIME should be prioritized in future development.

TL;DR: AI GGO detection is ready for prospective clinical trial evaluation, but requires testing in real screening populations with lower prevalence, alongside explainability features to support radiologist trust and collaboration.
Citation: Open Access, 2025. Available at: PMC12059966.